Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease

NCT: NCT06386497 · RECRUITING

NCT IDNCT06386497
StatusRECRUITING
Start Date2024-01-11
Completion2027-12-31
SponsorInsel Gruppe AG, University Hospital Bern (OTHER)
First posted
Last updated

Brief Summary

This pilot study aims to evaluate the feasibility and acceptability of nocturnal translational vestibular stimulations (VS) applied by a rocking bed (Somnomat Casa) for two months in patients with Parkinson's Disease.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑